Masimo Current Ratio 2007-2018 | MASI
Current and historical current ratio for Masimo (MASI) from 2007 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Masimo current ratio for the three months ending September 30, 2018 was 5.12.
| Masimo Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2018-09-30 | $0.74B | $0.14B | 5.12 |
| 2018-06-30 | $0.65B | $0.13B | 5.05 |
| 2018-03-31 | $0.60B | $0.13B | 4.55 |
| 2017-12-31 | $0.56B | $0.13B | 4.32 |
| 2017-09-30 | $0.55B | $0.17B | 3.17 |
| 2017-06-30 | $0.57B | $0.15B | 3.89 |
| 2017-03-31 | $0.56B | $0.20B | 2.75 |
| 2016-12-31 | $0.51B | $0.22B | 2.30 |
| 2016-09-30 | $0.33B | $0.14B | 2.25 |
| 2016-06-30 | $0.30B | $0.12B | 2.46 |
| 2016-03-31 | $0.32B | $0.12B | 2.65 |
| 2015-12-31 | $0.30B | $0.13B | 2.26 |
| 2015-09-30 | $0.30B | $0.11B | 2.66 |
| 2015-06-30 | $0.31B | $0.11B | 2.71 |
| 2015-03-31 | $0.32B | $0.12B | 2.69 |
| 2014-12-31 | $0.30B | $0.12B | 2.40 |
| 2014-09-30 | $0.30B | $0.24B | 1.25 |
| 2014-06-30 | $0.27B | $0.17B | 1.59 |
| 2014-03-31 | $0.29B | $0.10B | 2.96 |
| 2013-12-31 | $0.27B | $0.10B | 2.62 |
| 2013-09-30 | $0.26B | $0.10B | 2.53 |
| 2013-06-30 | $0.24B | $0.09B | 2.54 |
| 2013-03-31 | $0.23B | $0.10B | 2.37 |
| 2012-12-31 | $0.22B | $0.09B | 2.45 |
| 2012-09-30 | $0.26B | $0.08B | 3.08 |
| 2012-06-30 | $0.27B | $0.08B | 3.55 |
| 2012-03-31 | $0.27B | $0.09B | 2.98 |
| 2011-12-31 | $0.26B | $0.08B | 3.46 |
| 2011-09-30 | $0.28B | $0.07B | 4.19 |
| 2011-06-30 | $0.25B | $0.06B | 4.08 |
| 2011-03-31 | $0.23B | $0.06B | 3.67 |
| 2010-12-31 | $0.22B | $0.07B | 3.10 |
| 2010-09-30 | $0.25B | $0.07B | 3.55 |
| 2010-06-30 | $0.23B | $0.06B | 3.54 |
| 2010-03-31 | $0.22B | $0.07B | 3.01 |
| 2009-12-31 | $0.29B | $0.06B | 4.87 |
| 2009-09-30 | $0.28B | $0.06B | 4.87 |
| 2009-06-30 | $0.25B | $0.05B | 4.75 |
| 2009-03-31 | $0.24B | $0.06B | 4.02 |
| 2008-12-31 | $0.23B | $0.07B | 3.54 |
| 2008-09-30 | $0.22B | $0.05B | 4.06 |
| 2008-06-30 | $0.20B | $0.06B | 3.39 |
| 2008-03-31 | $0.17B | $0.06B | 3.18 |
| 2007-12-31 | $0.18B | $0.06B | 2.97 |
| 2007-09-30 | $0.18B | $0.06B | 2.77 |
| 2007-06-30 | $0.12B | $0.07B | 1.78 |
| 2007-03-31 | $0.00B | $0.00B | 0.00 |
| 2006-09-30 | $0.00B | $0.00B | 0.00 |
| 2006-06-30 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.869B | $0.798B |
| Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $101.646B | 22.71 |
| Intuitive Surgical (ISRG) | United States | $62.797B | 59.11 |
| Edwards Lifesciences (EW) | United States | $37.165B | 37.83 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.805B | 16.10 |
| IDEXX Laboratories (IDXX) | United States | $18.132B | 49.24 |
| ABIOMED (ABMD) | United States | $16.324B | 107.76 |
| Hologic (HOLX) | United States | $13.485B | 20.39 |
| DexCom (DXCM) | United States | $13.192B | 0.00 |
| Teleflex (TFX) | United States | $13.146B | 29.84 |
| Varian Medical Systems (VAR) | United States | $12.050B | 30.10 |
| STERIS (STE) | United Kingdom | $10.343B | 26.58 |
| Penumbra (PEN) | United States | $5.368B | 324.10 |
| LivaNova (LIVN) | United Kingdom | $4.892B | 31.40 |
| Globus Medical (GMED) | United States | $4.712B | 29.54 |
| Integra LifeSciences Holdings (IART) | United States | $4.349B | 21.19 |
| Wright Medical Group (WMGI) | Netherlands | $3.986B | 0.00 |
| Cantel Medical (CMD) | United States | $3.532B | 34.84 |
| Inogen (INGN) | United States | $3.029B | 65.39 |
| Tandem Diabetes Care (TNDM) | United States | $2.955B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.678B | 22.41 |
| Glaukos (GKOS) | United States | $2.417B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $2.298B | 20.71 |
| OPKO Health (OPK) | United States | $1.677B | 0.00 |
| Nevro (NVRO) | United States | $1.462B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.305B | 207.82 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.220B | 35.25 |
| Luminex (LMNX) | United States | $1.161B | 53.14 |
| Accelerate Diagnostics (AXDX) | United States | $1.073B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.067B | 0.00 |
| Intersect ENT (XENT) | United States | $1.019B | 0.00 |
| CryoLife (CRY) | United States | $0.999B | 108.12 |
| Natus Medical (BABY) | United States | $0.922B | 19.24 |
| Mesa Laboratories (MLAB) | United States | $0.897B | 36.71 |
| AngioDynamics (ANGO) | United States | $0.871B | 28.27 |
| ViewRay (VRAY) | United States | $0.765B | 0.00 |
| Veracyte (VCYT) | United States | $0.754B | 0.00 |
| AxoGen (AXGN) | United States | $0.673B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.632B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.475B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.445B | 0.00 |
| Si-Bone (SIBN) | United States | $0.438B | 0.00 |
| Accuray (ARAY) | United States | $0.433B | 0.00 |
| Fluidigm (FLDM) | United States | $0.405B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.372B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.353B | 0.00 |
| Neuronetics (STIM) | United States | $0.316B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.304B | 0.00 |
| Sientra (SIEN) | United States | $0.298B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.298B | 47.80 |
| IRadimed (IRMD) | United States | $0.290B | 61.72 |
| Nuvectra (NVTR) | United States | $0.247B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.179B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.163B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.137B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.121B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.093B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.093B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.085B | 0.00 |
| EDAP TMS (EDAP) | France | $0.082B | 0.00 |
| ConforMIS (CFMS) | United States | $0.080B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.074B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.067B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.061B | 0.00 |
| Vermillion (VRML) | United States | $0.060B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.056B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.049B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.038B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.034B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.031B | 0.00 |
| PAVmed (PAVM) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.025B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.024B | 0.00 |
| Neovasc (NVCN) | Canada | $0.019B | 0.00 |
| Dynatronics (DYNT) | United States | $0.018B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.014B | 45.67 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.013B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.011B | 0.00 |
| Avinger (AVGR) | United States | $0.010B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.009B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
